Skip to main content

Articles

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Page 19 of 50

  1. Epithelioid schwannoma as a rare variant poses a challenge to all pathologists, as this uncommon entity is extremely difficult to conclusively diagnose by morphological analyses on a resected sample alone owin...

    Authors: Sohsuke Yamada, Mari Kirishima, Tsubasa Hiraki, Michiyo Higashi, Kazuhito Hatanaka and Akihide Tanimoto
    Citation: Diagnostic Pathology 2017 12:11
  2. Combined thymic carcinoma is a malignant neoplasm of the thymus recently added to the 4th edition of the World Health Organization (WHO) classification of tumors of the lung, pleura, thymus and heart. It invol...

    Authors: Yufeng Jiang, Yang Liu, Xiuying Shi, Xiaoyun Mao, Yang Zhao and Chuifeng Fan
    Citation: Diagnostic Pathology 2017 12:9
  3. Giant cell ependymoma of the filum terminale is a rare variant, generally manifested as a well-circunscribed intradural mass with an indolent biological behavior.

    Authors: Fernando Candanedo-Gonzalez, Cindy Sharon Ortiz-Arce, Samuel Rosales-Perez, Ana Lilia Remirez-Castellanos, Candelaria Cordova-Uscanga and Armando Gamboa-Dominguez
    Citation: Diagnostic Pathology 2017 12:7
  4. Colorectal cancer is the major cause of cancer mortality, despite development of therapeutic strategies. The novel marker tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial heat sho...

    Authors: Min Gyoung Pak, Hyong Jong Koh and Mee Sook Roh
    Citation: Diagnostic Pathology 2017 12:6
  5. Despite new treatment options for hepatocellular carcinomas (HCC) recently, 5-year survival remains poor, ranging from 50 to 70%, which may attribute to the lack of early diagnostic biomarkers. Thus, developin...

    Authors: Feifei Wang, Ruliang Wang, Qiuwen Li, Xueling Qu, Yixin Hao, Jingwen Yang, Huixia Zhao, Qian Wang, Guanghui Li, Fengyun Zhang, He Zhang, Xuan Zhou, Xioumei Peng, Yang Bian and Wenhua Xiao
    Citation: Diagnostic Pathology 2017 12:4
  6. Double-hit lymphomas (DHL) are rare high-grade neoplasms characterized by two translocations: one involving the gene MYC and another involving genes BCL2 or BCL6, whose diagnosis depends on cytogenetic examinatio...

    Authors: Cristiano Claudino Oliveira, Helena Maciel-Guerra, Luan Kucko, Eric Jun Hirama, Américo Delgado Brilhante, Francisco Carlos Quevedo, Isabela Werneck da Cunha, Fernando Augusto Soares, Ligia Niero-Melo, Patrícia Pintor dos Reis and Maria Aparecida Custodio Domingues
    Citation: Diagnostic Pathology 2017 12:3
  7. The Cks1 protein is an essential factor in regulating cell cycle by mediating the ubiquitination of CDK inhibitor p27kip1. It has been reported that aberrant expression of Cks1 and p27kip1 proteins was found in v...

    Authors: Lina Xu, Songqing Fan, Jin Zhao, Peng Zhou, Shuzhou Chu, Jiadi Luo, Qiuyuan Wen, Lingjiao Chen, Sailan Wen, Li Wang and Lei Shi
    Citation: Diagnostic Pathology 2017 12:2
  8. Haploinsufficiency of the GATA6 transcription factor gene was recently found to be the most common cause of pancreatic agenesis, a rare cause of neonatal diabetes mellitus. Although most cases are de novo, we des...

    Authors: Daphne Yau, Elisa De Franco, Sarah E. Flanagan, Sian Ellard, Miriam Blumenkrantz and John J. Mitchell
    Citation: Diagnostic Pathology 2017 12:1
  9. Diffuse large B-cell lymphoma (DLBCL) typically leads to effacement of the nodal architecture by an infiltrate of malignant cells. Rarely (<1%), DLBCL can present with an interfollicular pattern (DLBCL-IF) pre...

    Authors: Joseph Hatem, April M. Schrank-Hacker, Christopher D. Watt, Jennifer J. D. Morrissette, Adam I. Rubin, Ellen J. Kim, Sunita D. Nasta, Mariusz A. Wasik and Agata M. Bogusz
    Citation: Diagnostic Pathology 2016 11:137
  10. The origin and heterogeneity of hepatic progenitor cells (HPCs) remain unclear. This study aimed to investigate the involvement of epithelial-mesenchymal transition (EMT) in the histogenesis of HPCs.

    Authors: Wei Xu, Nong-Rong Wang, Hua-Feng Wang, Qiong Feng, Jun Deng, Zhi-Qiang Gong, Jian Sun, Xiao-Liang Lou, Xue-Feng Yu, Lv Zhou, Jin-Ping Hu, Xiao-Feng Huang, Xiao-Qing Qi, Yan-Juan Deng, Rui Gong, Yan Guo…
    Citation: Diagnostic Pathology 2016 11:136
  11. Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has high short-term mortality with unknown causes. To predict this malignant condition in clinics is challenging. In this study, we aim to demonstra...

    Authors: Haiyan Min, Shanshan Fan, Shiyu Song, Yi Zhuang, Hui Li, Yongzheng Wu, Hourong Cai, Long Yi, Jinghong Dai and Qian Gao
    Citation: Diagnostic Pathology 2016 11:135
  12. Calcifying epithelial odontogenic tumor (CEOT) is a rare benign neoplasia, locally aggressive, that tends to invade bone and adjacent soft tissues. This case report describes the thirteenth known case of CEOT ...

    Authors: Cristina Munteanu, Daniel Pirici, Alex Emilian Stepan, Adrian Camen and Claudiu Margaritescu
    Citation: Diagnostic Pathology 2016 11:134
  13. Inhibition of the oncogenic fusion-gene EML4-ALK is a current first-line approach for patients with stage IV non-small cell lung cancer. While FISH was established as the gold standard for identifying these pa...

    Authors: Anna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, Clemens Lier, Carlota Porcel, Martina Kirchner, Jonas Leichsenring, Roland Penzel, Michael Thomas, Peter Schirmacher, Arne Warth and Albrecht Stenzinger
    Citation: Diagnostic Pathology 2016 11:133
  14. Inflammatory myofibroblastic tumor (IMT) is a rare low-grade malignant neoplasm with a predilection for children and young adults, and typically arises in the lung, abdominopelvic region, and retroperitoneum. ...

    Authors: Yoko Tateishi, Koji Okudela, Shigeo Kawai, Takehisa Suzuki, Shigeaki Umeda, Mai Matsumura, Mitomu Kioi and Kenichi Ohashi
    Citation: Diagnostic Pathology 2016 11:132
  15. Signet ring cells (SRCs) often accompany gastrointestinal carcinoma, referred to as SRC carcinoma; however, breast cancers containing SRCs have not been well characterized, leaving the prognostic significance ...

    Authors: Ryuji Ohashi, Ayako Hayama, Keiko Yanagihara, Koji Yamashita, Takashi Sakatani, Hiroyuki Takei and Zenya Naito
    Citation: Diagnostic Pathology 2016 11:131
  16. Uterine serous endometrial intraepithelial carcinoma (SEIC) is an immediate precursor of invasive carcinoma. The majority of stage IA SEICs are curable, but those with latent peritoneal metastasis and/or capil...

    Authors: Mitsuko Furuya, Teiko Sato, Reiko Tanaka, Masafumi Yamamoto, Naho Ruiz Yokota and Etsuko Miyagi
    Citation: Diagnostic Pathology 2016 11:130
  17. As the World Health Organization grading system for gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) may not always correlate with tumor progression, it is imperative that other independent predictors o...

    Authors: Yoichiro Okubo, Osamu Motohashi, Norisuke Nakayama, Ken Nishimura, Rika Kasajima, Yohei Miyagi, Manabu Shiozawa, Emi Yoshioka, Masaki Suzuki, Kota Washimi, Kae Kawachi, Madoka Nito, Yoichi Kameda and Tomoyuki Yokose
    Citation: Diagnostic Pathology 2016 11:128
  18. Authors: Samad Alimohammadi, Rahim Hobbenaghi, Javad Javanbakht, Danial Kheradmand, Reza Mortezaee, Maryam Tavakoli, Farshid Khadivar and Hamid Akbari
    Citation: Diagnostic Pathology 2016 11:125

    The original article was published in Diagnostic Pathology 2013 8:137

  19. Authors: Rahim Hobbenaghi, Pariya Mahboob, Siamak Saifzadeh, Javad Javanbakht, Javad Yaghoobi Yeganeh Manesh, Rasool Mortezaee, Seyed Rashid Touni, Ehsan Hosseini, Shahin Aghajanshakeri, Milad Moloudizargari and Soheil Javaherypour
    Citation: Diagnostic Pathology 2016 11:124

    The original article was published in Diagnostic Pathology 2014 9:59

  20. Authors: Alireza Nasoori, Behnam Pedram, Zahra Kamyabi-Moghaddam, Aram Mokarizadeh, Hamid Pirasteh, Amir Farshid Fayyaz and Mohammad Barat Shooshtari
    Citation: Diagnostic Pathology 2016 11:123

    The original article was published in Diagnostic Pathology 2015 10:23

  21. Authors: Abbas Tavasoly, Javad Javanbakht, Fariba Khaki, Ehsan Hosseini, Alimohammad Bahrami, Mehdi Aghamohammad Hassan and Mohammadmehdi Mirabad
    Citation: Diagnostic Pathology 2016 11:121

    The original article was published in Diagnostic Pathology 2013 8:777

  22. Authors: Farajollah Adib-Hashemi, Farshad Farahmand, Shamim Fattah Hesari, Bijan Rezakhaniha, Ehsan Fallah, Amir Farshid Fayyaz and Masoomeh Dadpay
    Citation: Diagnostic Pathology 2016 11:118

    The original article was published in Diagnostic Pathology 2015 10:19

  23. Authors: Fardin Barati, Javad Javanbakht, Farajollah Adib-Hashemi, Ehsan Hosseini, Reyhaneh Safaeie, Mojtaba Rajabian, Mostafa Razmjoo, Reza Sedaghat and Mehdi Aghamohammad Hassan
    Citation: Diagnostic Pathology 2016 11:117

    The original article was published in Diagnostic Pathology 2013 8:826

  24. Authors: Radmehr Shafiee, Javad Javanbakht, Nahid Atyabi, Alimohammad Bahrami, Danial Kheradmand, Reyhaneh Safaei, Farshid Khadivar and Ehsan Hosseini
    Citation: Diagnostic Pathology 2016 11:116

    The original article was published in Diagnostic Pathology 2013 8:136

  25. Authors: Javad Yaghoobi Yeganeh Manesh, Radmehr Shafiee, Ali Mohammad Bahrami, Mehdi Pourzaer, Maryam Pourzaer, Behnam Pedram, Javad Javanbakht, Aram Mokarizadeh and Farshid Khadivar
    Citation: Diagnostic Pathology 2016 11:115

    The original article was published in Diagnostic Pathology 2014 9:999

  26. Authors: Omid Maghsoudi, Seyed Hesamoddin Mirjalili, Mojtaba Dolatabadi, Mostafa Fallah Joshaghani, Mojtaba Zarea, Emad Yahaghi and Aram Mokarizadeh
    Citation: Diagnostic Pathology 2016 11:114

    The original article was published in Diagnostic Pathology 2015 10:98

  27. Authors: Afshin Taheriazam, Amir Jouya Talaei, Mohammad Jamshidi, Mohammadreza Shakeri, Samaneh Khoshbakht, Emad Yahaghi and Marjan Shokrani
    Citation: Diagnostic Pathology 2016 11:112

    The original article was published in Diagnostic Pathology 2015 10:184

  28. Authors: Naeemeh Ghasemkhani, Sahar Shadvar, Yasamin Masoudi, Amir Jouya Talaei, Emad Yahaghi, Peyman Karimi Goudarzi and Ebrahim Shakiba
    Citation: Diagnostic Pathology 2016 11:110

    The original article was published in Diagnostic Pathology 2015 10:164

  29. Authors: Rahim Hobbenaghi, Javad Javanbakht, Ehan Hosseini, Shahin Mohammadi, Mojtaba Rajabian, Pedram Moayeri and Mehdi Aghamohammad Hassan
    Citation: Diagnostic Pathology 2016 11:109

    The original article was published in Diagnostic Pathology 2013 8:123

  30. Authors: Fariba Khaki, Javad Javanbakht, Farhang Sasani, Mohammad Javad Gharagozlou, Alimohammad Bahrami, Hemmat Moslemzadeh and Reza Sheikhzadeh
    Citation: Diagnostic Pathology 2016 11:107

    The original article was published in Diagnostic Pathology 2013 8:98

  31. Authors: Ehsan Hosseini, Behnam Pedram, Ali Mohammad Bahrami, Mohammad Hossein Jaberi Moghaddam, Javad Javanbakht, Fatemeh Emami Ghomi, Najme Jaberi Moghaddam, Mobin Koohestani and Radmehr Shafiee
    Citation: Diagnostic Pathology 2016 11:106

    The original article was published in Diagnostic Pathology 2014 9:9

  32. Metanephric adenoma (MA) is a benign renal tumor that is difficult to distinguish from a malignant tumor via traditional radiography. The diagnosis of MA is often dependent on postsurgical histopathological ex...

    Authors: Jing Yan, Jing-Liang Cheng, Chen-Fei Li, Yan-Bang Lian, Yuan Zheng, Xue-Ping Zhang and Chao-Yan Wang
    Citation: Diagnostic Pathology 2016 11:104
  33. To assess the quality of sweat test (ST) based on the proportion of sweat sodium and sweat chloride as diagnostic parameter of cystic fibrosis (CF).

    Authors: Alethéa Guimarães Faria, Fernando Augusto Lima Marson, Carla Cristina de Souza Gomez, Maria Ângela Gonçalves de Oliveira Ribeiro, Lucas Brioschi Morais, Maria de Fátima Servidoni, Carmen Sílvia Bertuzzo, Eulália Sakano, Maura Goto, Ilma Aparecida Paschoal, Mônica Corso Pereira, Gabriel Hessel, Carlos Emílio Levy, Adyléia Aparecida Dalbo Contrera Toro, Andressa Oliveira Peixoto, Maria Cristina Ribeiro Simões…
    Citation: Diagnostic Pathology 2016 11:103

    The Erratum to this article has been published in Diagnostic Pathology 2017 12:22

  34. HER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a...

    Authors: Jennifer S. Woo, Sophia K. Apple, Peggy S. Sullivan, Jian-Yu Rao, Nora Ostrzega and Neda A. Moatamed
    Citation: Diagnostic Pathology 2016 11:102
  35. Mitotically active cellular fibroma (MACF) of the ovary, characterized by relatively high mitotic activity without severe atypia, represents a relatively new disease entity. MACF is categorized as a benign ova...

    Authors: Katsuya Matsuda, Seiko Tateishi, Yuko Akazawa, Akira Kinoshita, Shiko Yoshida, Sachiko Morisaki, Ai Fukushima, Takahiro Matsuwaki, Koh-Ichiro Yoshiura and Masahiro Nakashima
    Citation: Diagnostic Pathology 2016 11:101
  36. Isolated hypothalamic-pituitary Langerhans cell histiocytosis (HPLCH) is very rare. We investigated the clinicopathological characteristics, endocrine function changes, BRAFV600E mutations and treatments of isola...

    Authors: Zhen Huo, Tao Lu, Zhiyong Liang, Fan Ping, Jie Shen, Jingjing Lu, Wenbing Ma, Dachun Zhao and Dingrong Zhong
    Citation: Diagnostic Pathology 2016 11:100
  37. Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin and comprises the largest category of soft-tissue sarcomas both in children and adolescents. From a pediatric oncology point of view, RMS has t...

    Authors: Petra Balogh, Rita Bánusz, Monika Csóka, Zsófia Váradi, Edit Varga and Zoltán Sápi
    Citation: Diagnostic Pathology 2016 11:99

Annual Journal Metrics

  • 2022 Citation Impact
    2.6 - 2-year Impact Factor
    2.7 - 5-year Impact Factor
    1.096 - SNIP (Source Normalized Impact per Paper)
    0.677 - SJR (SCImago Journal Rank)

    2023 Speed
    22 days submission to first editorial decision for all manuscripts (Median)
    119 days submission to accept (Median)

    2023 Usage 
    1,109,481 downloads
    429 Altmetric mentions